Visp, Switzerland

Elie Saikali


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Cedars, PA (US) (2002)
  • Visp, CH (2001 - 2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Elie Saikali: Innovator in Pyrimidine Chemistry

Introduction

Elie Saikali is a notable inventor based in Visp, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of novel methods for synthesizing pyrimidine derivatives. With a total of 3 patents to his name, Saikali's work has implications in various applications within the pharmaceutical industry.

Latest Patents

Saikali's latest patents include a process for the preparation of N-(amino-4, 6-dihalo-pyrimidine) formamides. This innovative method focuses on producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]-cyclopent-2-enylmethanols. The invention describes a novel approach where amino-4,6-halopyrimidine is reacted with a 4-aminocyclopent-2-enylmethanol in the presence of a base in a polar protic solvent. This method showcases Saikali's expertise in organic synthesis and his commitment to advancing chemical processes.

Career Highlights

Throughout his career, Elie Saikali has worked with prominent companies such as Lonza AG and Lonza Group, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects. Saikali's work has been instrumental in enhancing the capabilities of these companies in the field of chemical manufacturing.

Collaborations

Elie Saikali has collaborated with various professionals in his field, including his coworker Walter Brieden. These collaborations have fostered an environment of innovation and have led to the successful development of new chemical processes.

Conclusion

Elie Saikali is a distinguished inventor whose work in pyrimidine chemistry has led to significant advancements in the field. His patents and collaborations reflect his dedication to innovation and his impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…